InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,630.68
(
0.53%
)
Post# of 252426
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

vinmantoo

Send PM Follow Ignore
Followers 30
Posts 4136
Boards Moderated 0
Alias Born 07/25/2007

vinmantoo

Re: dewophile post# 247613

Tuesday, 06/20/2023 7:02:18 PM

Tuesday, June 20, 2023 7:02:18 PM

Post# of 252426

although I don't think a challenge study is particularly costly (and enables them to combine their drugs if any segment of the phase 2s has suboptimal efficacy)



I would move forward with a challenge study for the reasons you state. Why would anyone be unhappy about it?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up